Latest filing published 22 May 2026 for Privia Health Group, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lance Berberian (senior executive) discloses dealings in 2 companies, chiefly Labcorp Holdings Inc. and Privia Health Group, Inc. The record holds 24 filings, for trades running from 11 February 2016 to 20 May 2026.
Every open-market trade on record is a sale: 1 sale worth €471k. Other entries cover 9 share grants and 14 option exercises.
The latest filing, published on 22 May 2026, reports a share grant in Privia Health Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations